Healthy Beginning Initiative
NCT01795261 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5400
Last updated 2015-12-02
Summary
The purpose of this study is to determine if providing free laboratory test to pregnant women and their spouses at churches, in addition to laboratories or hospitals, will increase the number of pregnant women and their spouses who get screened for HIV, malaria, sickle cell trait, hemoglobin levels, syphilis, and hepatitis B. These tests are necessary to keep mothers healthy during pregnancy and lead to healthy babies. This research is taking place in 40 churches in Nigeria.
Conditions
Sponsors & Collaborators
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
collaborator NIH -
University of Nevada, Reno
lead OTHER
Principal Investigators
-
Echezona Ezeanolue, MD · University of Nevada, Reno
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-09-30
- Primary Completion
- 2016-09-30
- Completion
- 2016-09-30
Countries
- Nigeria
Study Locations
More Related Trials
-
Antiretroviral Drug Levels During and After Pregnancy
NCT00616252 ·Status: COMPLETED
-
Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy
NCT00017719 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo
NCT03048669 ·Status: COMPLETED ·Phase: NA
-
Supporting Oral and Long-acting PrEP Decision Making Among Pregnant Women in Lilongwe, Malawi
NCT06397690 ·Status: COMPLETED ·Phase: NA
-
Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women
NCT00017797 ·Status: COMPLETED
-
Primary HIV Prevention in Pregnant and Lactating Ugandan Women
NCT01882998 ·Status: COMPLETED ·Phase: NA
-
Assessing the Feasibility, Acceptability and Effects Of HIV Birth Testing In Maternity Settings In Zimbabwe
NCT04206241 ·Status: COMPLETED
-
Neonatal HIV Early Infant Diagnosis (EID) Versus Standard of Care EID- Long Term Impact on inFant hEalth (LIFE)
NCT04032522 ·Status: COMPLETED
-
HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure
NCT03642704 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns
NCT00006396 ·Status: COMPLETED ·Phase: PHASE3
-
ART Readiness in HIV-infected Pregnant Women
NCT02459678 ·Status: COMPLETED ·Phase: NA
-
Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral Treatment
NCT06267508 ·Status: RECRUITING
-
A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries
NCT00341302 ·Status: COMPLETED
-
An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women
NCT04330989 ·Status: COMPLETED ·Phase: NA
-
HIV Diagnosis in Hospitalized Malawian Infants
NCT01388452 ·Status: COMPLETED ·Phase: NA
-
The Impact of Mentor Mothers on PMTCT Service Outcomes in Nigeria
NCT01936753 ·Status: COMPLETED ·Phase: NA
-
Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIV
NCT06999928 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the HITSystem to Improve Early Infant Diagnosis Outcomes in Kenya
NCT02072603 ·Status: COMPLETED ·Phase: NA
-
HIV Testing in Pregnant Women: Evaluating an Opt-Out Testing Strategy
NCT00393302 ·Status: COMPLETED
-
Early ART Initiation Among HIV-positive Pregnant Women in Central Mozambique
NCT02371265 ·Status: COMPLETED ·Phase: NA
-
HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV
NCT00442962 ·Status: COMPLETED ·Phase: PHASE4
-
Piloting At-birth Point of Care HIV Testing Strategies in Kenya
NCT03435887 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Antiretroviral Agents in HIV-1 Infected Pregnant Women
NCT00006320 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Point-of-Care EID for HIV-Exposed Infants
NCT03824067 ·Status: COMPLETED ·Phase: NA
-
A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
NCT00000751 ·Status: COMPLETED ·Phase: PHASE3